Skip to main content

MoneyWorks4Me

CARE reaffirms rating assigned to bank facilities of Cipla

22 Jan 2016 Evaluate

Credit rating agency, Credit Analysis and Research (CARE) has reaffirmed ‘AAA / A1+’ rating to the various bank facilities of Cipla for an aggregate amount of Rs 3,310.50 crore.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 150 countries. Its portfolio includes 1500 plus products across therapeutic categories with one quality standard globally.


Peers
Company Name CMP
Sun Pharma. Inds. 1886.80
Dr. Reddys Labs. 1386.00
Cipla 1410.00
Lupin 2014.00
Zydus Lifesciences 1205.50
View more..